GenoLogics and CLC bio will provide an end-to-end informatics and analysis solution, optimized for Next Generation Sequencing research that addresses both lab and data management and data analysis all within one integrated system.
Archive for the ‘men sex health’ Category
GenoLogics and CLC bio to Provide End-to-End Genomics Informatics and Analysis for Next Generation Sequencing
Friday, November 27th, 2009CLC bio expanding network to deliver NGS to the Japanese market
Friday, November 27th, 2009CLC bio has started a new expansion phase of the distribution of its NGS solutions into the Japanese market.
Accurate and fast methods to estimate the population mutation rate from error prone sequences
Friday, November 27th, 2009CSO at CLC bio, Bjarne Knudsen and Michael M. Miyamoto from the University of Florida recently wrote an article in BMC Bioinformatics.
BIOBASE and CLC bio partner to give genomics researchers world class solution
Friday, November 27th, 2009At the Biotechnica / Bio-IT World Europe conference in Hannover, Germany, BIOBASE and CLC bio announced a partnership to integrate BIOBASE’s comprehensive TRANSFAC® database with CLC bio’s popular workbenches and award-winning server solution.
CLC bio produce the most reliable mapping results according to article published in PLoS ONE
Friday, November 27th, 2009Last week Nicola Palmieri and Christian Schlötterer of Institut für Populationsgenetik, Veterinärmedizinische Universität Wien, Vienna, Austria, published an article in PLoS ONE, Vol. 4, No. 7. (28 July 2009), e6323, under the headline Mapping Accuracy of Short Reads from Massively Parallel Sequencing and the Implications for Quantitative Expression Profiling
CLC bio delivers specialized immunoinformatics solution to Symphogen
Friday, November 27th, 2009CLC bio has just completed a specialized immunoinformatics solution that is fully customized to fit into Symphogen’s proprietary Symplex™ technology for high throughput identification of antibodies with diversity and specificity customized to a particular therapeutic application.
RainDance Technologies and CLC bio Collaborate to Develop Specialized Software Solutions for Targeted Resequencing
Friday, November 27th, 2009RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next generation DNA sequencing platforms.
JCVI improves its metagenomics annotation pipeline with high-performance computing solution from CLC bio
Friday, November 27th, 2009The J. Craig Venter Institute (JCVI) in Rockville, Maryland, has recently incorporated CLC bio’s accelerated versions of the algorithms Hmmpfam and Hmmsearch into their bioinformatics pipeline for functional annotation of proteins identified in metagenomics data. The algorithms originate from Dr. Sean Eddy’s popular HMMER package but their core parts have been accelerated by CLC bio using SIMD technology.
The University of Queensland signs agreement with CLC bio
Friday, November 27th, 2009The University of Queensland and CLC bio have signed an agreement, providing each student enrolled in the university’s genetics courses with a copy of CLC Main Workbench, worth more than $2 million USD over four years.
CLC bio reveals biocomputing solution at ISMB 2009 in Stockholm
Friday, November 27th, 2009At the 17th international conference on Intelligent Systems for Molecular Biology (ISMB) and 8th European Conference on Computational Biology (ECCB) in Stockholm, Sweden, we have revealed our first turnkey biocomputing solution for analyzing and visualizing Next Generation Sequencing data, called CLC Genomics Machine.